SBIO

ALPS Medical Breakthroughs ETFALPS Funds$53.80-0.58 (-1.07%)

AUM $205.8MER 0.50%NAV $56.77Holdings 103Inception Dec 2014

Price Chart

Key Statistics

Previous Close

$54.38

Day Range

$53.80$53.80

52-Week Range

$39.93$70.79

Avg Volume

49.2K

Dividend Yield

2.29%

Expense Ratio

0.50%

AUM

$205.8M

Shares Outstanding

3.2M

ETF Grades

?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.

Sector Breakdown

Sector	Weight %
Healthcare	100.00%

Country Allocation

Country	Weight %
United States	88.99%
Canada	2.43%
United Kingdom	2.19%
Netherlands	1.86%
China	1.85%
Belgium	1.51%
Germany	0.81%
Switzerland	0.35%
Other	0.01%

Fund Information

Issuer: ALPS Funds
Category: Healthcare
Types: Healthcare
Inception Date: Dec 30, 2014
Exchange: NYSE_ARCA
Description: The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).

Similar ETFs

Symbol	Name	AUM	Expense Ratio	Holdings
SCHD	Schwab U.S. Dividend Equity ETF	$108.39B	0.06%	102
IWM	iShares Russell 2000 ETF	$77.54B	0.19%	1,986
XLV	State Street Health Care Select Sector SPDR ETF	$42.73B	0.08%	61
VHT	Vanguard Health Care ETF	$22.00B	0.09%	411
SCHA	Schwab U.S. Small-Cap ETF	$21.79B	0.03%	1,755

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund issued by ALPS Funds that launched on Dec 30, 2014. It currently manages $205.8M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 103 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 30.7% of the fund

Rank	Symbol	Name	Weight %	Shares	Market Value
1	CGON	CG oncology Inc.	3.90%	117,456	$8.0M
2	ORKA	Oruka Therapeutics Inc.	3.56%	87,745	$7.3M
3	TVTX	Travere Therapeutics Inc.	3.45%	124,893	$7.1M
4	DFTX	Definium Therapeutics Inc.	3.25%	178,006	$6.7M
5	DNTH	Dianthus Therapeutics Inc.	3.18%	74,082	$6.5M
6	MANE	VeraDermics Inc.	3.15%	55,356	$6.5M
7	EWTX	Edgewise Therapeutics Inc.	2.83%	143,864	$5.8M
8	RLAY	Relay Therapeutics Inc.	2.61%	290,321	$5.4M
9	XENE	Xenon Pharmaceuticals Inc.	2.43%	128,289	$5.0M
10	IDYA	Ideaya Biosciences Inc.	2.35%	127,829	$4.8M
11	AMLX	Amylyx Pharmaceuticals Inc.	2.27%	166,303	$4.7M
12	ACAD	ACADIA Pharmaceuticals Inc.	2.21%	228,308	$4.5M
13	TARS	Tarsus Pharmaceuticals Inc.	2.13%	58,130	$4.4M
14	DNLI	Denali Therapeutics Inc.	2.11%	211,772	$4.3M
15	DYN	Dyne Therapeutics Inc.	1.90%	247,403	$3.9M

Page 1 of 3

Detailed Returns

Period	ETF	Cat. Avg
1D	-1.07%	—
1W	-7.15%	—
1M	-19.49%	—
3M	-21.96%	—
6M	-0.27%	—
YTD	+7.26%	—
1Y	+34.73%	—
3Y	+102.64%	—
5Y	+18.11%	—

Moving Averages

20-Day MA

$60.31

Below 20-Day MA

50-Day MA

$64.43

Below 50-Day MA

200-Day MA

$56.79

Below 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$70.79

Current Price

$53.80

52-Week Low

$39.93

$39.93$70.79

Current Yield

2.29%

Annual Dividend

$1.2764

Frequency

1x/year

Last Ex-Date

Dec 19, 2024

Dividend History

Ex-Date	Amount	Pay Date
Dec 19, 2024	$1.1735	Dec 26, 2024
Dec 21, 2023	$0.0711	Dec 27, 2023
Dec 19, 2019	$0.0160	Dec 27, 2019
Dec 19, 2019	$0.0158	Dec 27, 2019
Dec 20, 2018	$0.7841	Dec 27, 2018
Dec 20, 2018	$0.7840	Dec 27, 2018
Dec 21, 2017	$0.5795	Dec 28, 2017
Dec 21, 2017	$0.5790	Dec 28, 2017

Dividend Payments Over Time

Category Comparison

Metric	SBIO	Healthcare(231 ETFs)	Healthcare(24 ETFs)
Fund Info
Expense Ratio	0.50%	0.62%	0.47%
AUM	$205.8M	$1.98B	$799.8M
Dividend Yield	2.29%	4.11%	1.61%
Avg Volume	49.2K	491.6K	95.8K
Holdings	103	178	172
Performance
1-Month Return	-19.63%	-4.15%	-5.35%
6-Month Return	-2.05%	+5.09%	+4.99%
YTD Return	+6.17%	+9.06%	+5.30%
1-Year Return	+8.41%	+8.39%	+5.56%

Compare with Another ETF

Search for an ETF to compare with SBIO:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.